Compounds > varenicline
Page last updated: 2024-09-05

varenicline and Cardiovascular Stroke

varenicline has been researched along with Cardiovascular Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Chan, KC; Chang, KW; Li, LC; Lo, CH; Lo, TH; Su, CH; Tsai, CF; Yen, CH1
Eberg, M; Filion, KB; Platt, RW; Reynier, P1
Davies, NM; Douglas, I; Gunnell, D; Martin, RM; Taylor, AE; Taylor, GMJ; Thomas, KH1
Gulati, M; Hellkamp, A; Pagidipati, NJ; Peterson, ED; Thomas, L; Wang, TY1
Davies, NM; Jones, T; Martin, RM; Munafò, MR; Taylor, AE; Taylor, GMJ; Thomas, KH; Windmeijer, F1
Hering, T1

Other Studies

6 other study(ies) available for varenicline and Cardiovascular Stroke

ArticleYear
Safety and efficacy of early varenicline prescription in hospitalized patients with acute myocardial infarction: East Asian population.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2023, Volume: 122, Issue:10

    Topics: Aged; East Asian People; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotinic Agonists; Smoking Cessation; Treatment Outcome; Varenicline

2023
Estimation of high-dimensional propensity scores with multiple exposure levels.
    Pharmacoepidemiology and drug safety, 2020, Volume: 29 Suppl 1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Bupropion; Cohort Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Nicotine; Pharmacoepidemiology; Propensity Score; Proportional Hazards Models; Retrospective Studies; Smoking Cessation; United Kingdom; Varenicline; Young Adult

2020
Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study.
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:6

    Topics: Adult; Aged; Benzazepines; Bupropion; Cross-Over Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Self-Injurious Behavior; Smoking Cessation; Suicide; Tobacco Use Cessation Devices; United Kingdom; Varenicline

2021
Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice.
    JAMA cardiology, 2017, 09-01, Volume: 2, Issue:9

    Topics: Age Factors; Aged; Bupropion; Comorbidity; Female; Humans; Lung Diseases; Male; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Peripheral Arterial Disease; Secondary Prevention; Sex Factors; Smoking Cessation; Smoking Cessation Agents; Varenicline

2017
The effects of prescribing varenicline on two-year health outcomes: an observational cohort study using electronic medical records.
    Addiction (Abingdon, England), 2018, Volume: 113, Issue:6

    Topics: Body Mass Index; Case-Control Studies; Cause of Death; Cohort Studies; Electronic Health Records; Hospitalization; Longitudinal Studies; Mortality; Myocardial Infarction; Primary Health Care; Propensity Score; Pulmonary Disease, Chronic Obstructive; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Cessation Devices; United Kingdom; Varenicline; Weight Gain

2018
[Smoking cessation--assistance for the general practitioner].
    MMW Fortschritte der Medizin, 2011, Apr-07, Volume: 153, Issue:14

    Topics: Benzazepines; Bupropion; Combined Modality Therapy; Complementary Therapies; Cost-Benefit Analysis; Drug Costs; Fee Schedules; Germany; Humans; Myocardial Infarction; National Health Programs; Nicotine; Nicotinic Agonists; Physician's Role; Polymethacrylic Acids; Polyvinyls; Psychotherapy, Group; Quinoxalines; Smoking Cessation; Social Support; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline

2011